Liraglutide - Latest Advances

Sintilimab-related fulminant autoimmune diabetes mellitus manifesting as diabetic ketoacidosis and rare insulin resistance: A case report and literature review.

Journal: Endocrine journal

Published: October 13, 2025

Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes.

Journal: JAMA network open

Published: October 13, 2025

Effect of GLP-1 receptor agonists on body composition.

Journal: Current opinion in endocrinology, diabetes, and obesity

Published: October 12, 2025

Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) and the Clinical Outcomes of Inflammatory Bowel Disease (IBD): A Systematic Review and Meta-analysis.

Journal: Journal of Crohn's & colitis

Published: October 10, 2025

Transpupillary in vivo two-photon imaging reveals enhanced surveillance of retinal microglia in diabetic mice.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 08, 2025

Liraglutide and empagliflozin alleviate diabetic cardiomyopathy by reducing oxidative stress and inflammation.

Journal: Gaceta medica de Mexico

Published: October 08, 2025

Semaglutide (Wegovy) for MASH.

Journal: The Medical letter on drugs and therapeutics

Published: October 08, 2025

Adherence and Effectiveness of Liraglutide in Adolescents with Obesity.

Journal: Childhood obesity (Print)

Published: October 06, 2025

Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study.

Journal: Gut microbes

Published: September 29, 2025

Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: September 27, 2025

Correction: Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial.

Journal: Cardiovascular diabetology. Endocrinology reports

Published: September 27, 2025

Alpha-to-beta cell crosstalk: Adaptive mechanisms shaping islet function.

Journal: Advances in biological regulation

Published: September 24, 2025

Filters

Sintilimab-related fulminant autoimmune diabetes mellitus manifesting as diabetic ketoacidosis and rare insulin resistance: A case report and literature review.

Sintilimab-related fulminant autoimmune diabetes mellitus manifesting as diabetic ketoacidosis and rare insulin resistance: A case report and literature review.

Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes.

Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes.

Effect of GLP-1 receptor agonists on body composition.

Effect of GLP-1 receptor agonists on body composition.

Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) and the Clinical Outcomes of Inflammatory Bowel Disease (IBD): A Systematic Review and Meta-analysis.

Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RA) and the Clinical Outcomes of Inflammatory Bowel Disease (IBD): A Systematic Review and Meta-analysis.

Transpupillary in vivo two-photon imaging reveals enhanced surveillance of retinal microglia in diabetic mice.

Transpupillary in vivo two-photon imaging reveals enhanced surveillance of retinal microglia in diabetic mice.

Liraglutide and empagliflozin alleviate diabetic cardiomyopathy by reducing oxidative stress and inflammation.

Liraglutide and empagliflozin alleviate diabetic cardiomyopathy by reducing oxidative stress and inflammation.

Semaglutide (Wegovy) for MASH.

Semaglutide (Wegovy) for MASH.

Adherence and Effectiveness of Liraglutide in Adolescents with Obesity.

Adherence and Effectiveness of Liraglutide in Adolescents with Obesity.

Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study.

Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study.

Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment.

Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment.

Correction: Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial.

Correction: Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial.

Alpha-to-beta cell crosstalk: Adaptive mechanisms shaping islet function.

Alpha-to-beta cell crosstalk: Adaptive mechanisms shaping islet function.